These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 32660221

  • 21. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT.
    Oncotarget; 2016 Feb 02; 7(5):5702-14. PubMed ID: 26744318
    [Abstract] [Full Text] [Related]

  • 22. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M, Wang F, Mi H, Li L, Wang J, Han M, Gu Y.
    Cell Cycle; 2020 Dec 02; 19(23):3277-3288. PubMed ID: 33121324
    [Abstract] [Full Text] [Related]

  • 23. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
    Hargraves KG, He L, Firestone GL.
    Mol Carcinog; 2016 May 02; 55(5):486-98. PubMed ID: 25789847
    [Abstract] [Full Text] [Related]

  • 24. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
    Zheng SZ, Sun P, Wang JP, Liu Y, Gong W, Liu J.
    World J Gastroenterol; 2019 Jun 14; 25(22):2752-2762. PubMed ID: 31235998
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
    Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, Caplen NJ.
    Breast Cancer Res Treat; 2011 Nov 14; 130(2):663-79. PubMed ID: 21814748
    [Abstract] [Full Text] [Related]

  • 27. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B, Mohammadi A, Ghasabi M, Shirjang S, Dehghan R, Montazeri V, Holmskov U, Kazemi T, Duijf P, Gjerstorff M, Baradaran B.
    J Cell Physiol; 2019 Jun 14; 234(6):9816-9825. PubMed ID: 30480817
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
    Long J, Ou C, Xia H, Zhu Y, Liu D.
    Tumour Biol; 2015 Nov 14; 36(11):8697-702. PubMed ID: 26047605
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer.
    Hajalirezay Yazdi S, Paryan M, Mohammadi-Yeganeh S.
    Cell Mol Biol Lett; 2018 Nov 14; 23():51. PubMed ID: 30386383
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Suppressive effect of exogenous miR-16 and miR-34a on tumorigenesis of breast cancer cells.
    Haghi M, Taha MF, Javeri A.
    J Cell Biochem; 2019 Aug 14; 120(8):13342-13353. PubMed ID: 30916815
    [Abstract] [Full Text] [Related]

  • 38. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H, Lin J, Jiang J, Ji J, Wang C, Zhang J.
    Cell Cycle; 2020 Nov 14; 19(21):2939-2954. PubMed ID: 33044899
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.